# Dose Ranging Study in Elective Total Hip Replacement Surgery

> **NCT00338897** · PHASE2,PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 1090 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** SR123781A

## Key facts

- **NCT ID:** NCT00338897
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 1090 (ACTUAL)
- **Last updated:** 2008-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00338897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00338897, "Dose Ranging Study in Elective Total Hip Replacement Surgery". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00338897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*